News & Events
-
December 19, 2018
In Recognition of 10th Anniversary, Raymond Woosley and Janet Woodcock Address CPAD Consortium’s 2018 Annual Meeting and Regulatory Science Workshop
At its 10th Annual Meeting and Regulatory Science Workshop, November 13, 2018, in Bethesda, MD, C-Path’s Critical Path for Alzheimer’s Disease (CPAD) consortium hosted key stakeholders who gathered to review the progress made made over the past year and identify and prioritize regulatory science needs for Alzheimer disease (AD) and related dementias. At the meeting,... -
November 5, 2018
Critical Path Institute Rebrands One of Its First Consortia to Highlight Focus on Alzheimer’s Disease
Critical Path for Alzheimer’s Disease (CPAD) consortium’s refined, refocused mission centers on accelerating therapy development for AD and related forms of dementia TUCSON, Ariz., November 5, 2018 — The Critical Path Institute (C-Path) is pleased to announce that its Critical Path for Alzheimer’s Disease (CPAD) consortium has refined and refocused its mission in celebration of... -
August 10, 2018
CPAD’s Has Two Posters Accepted to Alzheimer’s Association International Conference
The Alzheimer’s Association International Conference (AAIC) is the largest annual scientific meeting with focus on Alzheimer disease (AD). More than 6,500 researchers and participants from pharma, academia, patent-advocacy organizations and other groups came together in Chicago between July 22nd and 26th to exchange the latest developments and research results. Each year, on behalf of our... -
May 2, 2016
Coalition Against Major Diseases (CAMD) Becomes a Partner in Massive Global Alzheimer’s Research Data-Sharing Network
May 2, 2016 Coalition Against Major Diseases (CAMD) Becomes a Partner in Massive Global Alzheimer’s Research Data-Sharing Network TUCSON, Ariz. — May 2, 2016 — The Critical Path Institute’s (C-Path) Coalition Against Major Diseases (CAMD) is announcing it will integrate its Alzheimer’s clinical trial data into the Global Alzheimer’s Association Interactive Network (GAAIN)... -
April 27, 2015
Critical Path Institute Secures Regulatory Support For Parkinson’s And Alzheimer’s Disease Biomarkers
April 27, 2015 Critical Path Institute Secures Regulatory Support For Parkinson’s And Alzheimer’s Disease Biomarkers FDA Endorses Biomarkers for Use in Early Stages of Brain Disease TUCSON, Ariz., April 27, 2015 — Critical Path Institute (C-Path) announced that the U.S. Food and Drug Administration (FDA) has issued three Letters of Support to C-Path’s Coalition Against...